InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Peters Richard, Président et CEO. Insider active across 3 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 15 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €55k. History available since 30 June 2021. The latest transaction was disclosed on 23 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Peters Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
3,135 sharesCommon StockSEC:0001104659-26-075283:0
101,891 sharesCommon StockSEC:0000950170-25-093015:0
12,500 shares@ US$0.61166.1% of flowCommon StockSEC:0000950170-25-090144:0
1,045 shares0Common StockSEC:0001104659-25-057821:0
1,045 shares0Common StockSEC:0001104659-24-073943:0
500 shares0Common StockSEC:0001104659-23-095018:0
1,931 shares@ US$1.86100.0% of flowCommon StockSEC:0001209191-22-062282:0
10,890 shares@ US$1.691312.6% of flowCommon StockSEC:0000899243-22-037790:0
5,995 shares0Common StockSEC:0001104659-22-084770:0
4,584 shares@ US$1.84916.0% of flowCommon StockSEC:0000899243-22-025399:0
10,206 shares@ US$1.194611.7% of flowCommon StockSEC:0000899243-22-021283:0
10,715 shares@ US$1.845518.6% of flowCommon StockSEC:0000899243-22-012782:0
70,000 shares0Common StockSEC:0000899243-21-046760:0
4,441 shares@ US$11.1143.1% of flowCommon StockSEC:0000899243-21-027794:0
4,610 shares0Common StockSEC:0001567619-21-012873:0
15 of 15 declarations
About Peters Richard
Peters Richard is Président et CEO. He has 15 filings, and across the 15 filings recorded, the sampled recent transactions span 2021-07-01 to 2026-06-17, with EUR 0 of buys and EUR 55084 of sells. His listed companies are Aprea Therapeutics, Inc., where he is Director, Yumanity Therapeutics, INC., where he is President and CEO, and Kineta, Inc./de, where he is Director.
